Pfizer News, Articles and Archives | CenterWatch News Online

Pfizer

1 2 3 4 5 6 7 8 9 10 Next 10

Bayer, Ventana collaborate on test for personalized cancer therapy

Wednesday, January 18, 2012 12:05 PM

Bayer Pharma has collaborated with Ventana Medical Systems, a member of the Roche Group, to develop a molecular companion diagnostic test to identify patients most likely to benefit from a novel Bayer antibody-drug conjugate (ADC).

More... »

Pfizer initiates phase I trial for Hemophilia drug

Monday, January 9, 2012 09:36 AM

Pfizer has initiated a phase I clinical trial for PF-05280602, an engineered variant of recombinant human Factor VIIa developed by Catalyst Biosciences.

More... »

Roese joins Marken

Thursday, December 22, 2011 11:29 AM

Marken has named Steve Roese vice president of its global quality assurance organization, which will support Marken's continued investment in their expanding network of pharmaceutical service depots around the world.

More... »

Russia's cancer drug market to grow to $163 million

Wednesday, December 14, 2011 12:48 PM

Decision Resources, a research and advisory firm for pharmaceutical and healthcare issues, has found that the Russian market for non-small-cell lung cancer therapies will grow 3% annually from 2010 to 2015 to $163 million in 2015. According to the Emerging Markets report, Non-Small-Cell Lung Cancer in Russia, an increase in the incident population, gradually increasing use of higher-priced chemotherapies and the introduction of several premium-priced agents will promote this growth.

More... »

Benedyk joins Amarantus as strategic advisor

Tuesday, December 13, 2011 09:29 AM

Amarantus BioSciences has named Mark J. Benedyk, PhD, strategic advisor effective immediately. In this role, he will support the company with strategy and business development issues.

More... »

UCB inks strategic partnerships with Parexel, PRA

Monday, November 28, 2011 08:00 AM

The sponsor-CRO strategic partnerships just keep coming.

More... »

Isis to receive $14 million from Pfizer's Excaliard acquisition

Tuesday, November 22, 2011 11:12 AM

Isis Pharmaceuticals will receive up to $14 million from Pfizer for its equity ownership of Excaliard Pharmaceuticals from Pfizer's acquisition of Excaliard. Upon closing of the acquisition, Isis will receive an initial $4.4 million. Contingent payments of up to an additional $9.6 million could be paid to Isis upon achievement of various milestones associated with the clinical and commercial progress of EXC 001. Isis will continue to be eligible for milestone and royalty payments under its licensing agreement with Excaliard for EXC 001.

More... »

U.K.’s MRN brings its home services for patients to U.S. market, predicting big growth in clinical trials use

Monday, November 14, 2011 08:02 AM

U.K.-based Medical Research Network (MRN), a five-year-old company that arranges for clinical trial participants to be seen in their homes rather than requiring them to travel to an investigative site, recently announced it is establishing a presence in the U.S. via a new office in Raleigh, N.C.

More... »

Dendreon names Fenton to board of directors

Tuesday, November 8, 2011 10:12 AM

Dendreon has named Dennis M. Fenton to the board of directors, effective November 8, 2011.

More... »

Report: Clinical trials approved in Russia on course in third quarter

Monday, November 7, 2011 11:26 AM

The number of new studies approved in Russia during the third quarter of 2011 reached last year’s level, with the Ministry of Health and Social Development of the Russian Federation (MoH) approving 132 new clinical trials of all types, including local and bioequivalence studies, according to Synergy Research Group (SynRG), a Russia-based CRO. That’s only two trials below the number approved in the year-ago quarter.

More... »

1 2 3 4 5 6 7 8 9 10 Next 10

CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

Date»
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
Region»
- U.S.
- Europe
- Asia
- Emerging Markets
- Global
Company Index
Search

CenterWatch Clinical Trials Data Library

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

centerwatch.com/jobwatch

Featured Jobs

More Jobs